Quoin Pharmaceuticals Announced Interim Analysis Of First Six Patients To Complete 12 Weeks Of Treatment Met Pre-Specified Alpha Adjusted Target For Primary Endpoint With Statistical Significance

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

Comments

No comments yet. Be the first!